US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist

1.430
+0.030+2.14%

Close Jul 1 16:00 ET

1.292
-0.138-9.65%

Pre 08:00 ET

55.82MMarket Cap-781P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-98.21%802K

-98.04%334K

-96.88%468K

16,580.22%44.7M

645,800.00%6.46M

32,347.37%6.17M

48,651.43%17.06M

Operating revenue

--0

-98.21%802K

--0

-98.04%334K

-96.88%468K

16,580.22%44.7M

645,800.00%6.46M

32,347.37%6.17M

48,651.43%17.06M

Cost of revenue

Gross profit

Operating expense

-21.52%16.32M

71.05%81.26M

-38.18%19.45M

4,393.95%14.9M

769.82%26.11M

56.17%20.8M

14.50%47.5M

103.56%31.46M

-107.55%-347K

-81.24%3M

Selling and administrative expenses

-50.62%5.99M

523.12%39.84M

-29.69%13.62M

108.89%961K

--13.13M

231.37%12.14M

-74.54%6.39M

97.88%19.37M

-1,013.43%-10.82M

----

-General and administrative expense

-50.62%5.99M

523.12%39.84M

-29.69%13.62M

108.89%961K

--13.13M

231.37%12.14M

-74.54%6.39M

97.88%19.37M

-1,013.43%-10.82M

----

Research and development costs

21.65%10.53M

0.74%41.41M

-51.77%5.83M

33.16%13.94M

45.99%12.98M

-10.32%8.66M

151.13%41.11M

113.35%12.1M

206.80%10.47M

144.74%8.89M

Other operating expenses

---205K

----

---5.89M

Operating profit

19.71%-16.32M

-2,772.30%-80.45M

22.22%-19.45M

-328.81%-14.9M

-283.33%-25.78M

-1,294.30%-20.33M

93.20%-2.8M

-61.77%-25M

242.28%6.51M

188.05%14.06M

Net non-operating interest income expense

-51.95%763K

-7.62%2.85M

-56.78%564K

-81.74%189K

-23.26%508K

17,544.44%1.59M

215.68%3.08M

7,350.00%1.31M

1.04M

662K

Non-operating interest income

-51.20%775K

-7.28%2.88M

-56.87%571K

-81.06%196K

-21.97%522K

1,813.25%1.59M

155,050.00%3.1M

--1.32M

--1.04M

--669K

Non-operating interest expense

--12K

47.37%28K

--7K

100.00%14K

--0

-99.29%19K

----

--7K

Other net income (expense)

90.83%1.08M

50.00%774K

-2K

507.84%310K

107.82%567K

54.03%516K

1,800.00%51K

Other non- operating income (expenses)

----

90.83%1.08M

50.00%774K

---2K

507.84%310K

----

70.78%567K

54.03%516K

----

1,800.00%51K

Income before tax

16.98%-15.56M

-9,102.59%-76.52M

21.88%-18.11M

-294.95%-14.71M

-268.95%-24.96M

-1,195.21%-18.74M

101.66%850K

-53.13%-23.18M

264.89%7.55M

192.49%14.77M

Income tax

92.83%-37K

31.22%-3.08M

59.39%-820K

10.53%-603K

-24.15%-1.14M

40.21%-516K

-15,867.86%-4.47M

-6,409.38%-2.02M

-9,528.57%-674K

-7,725.00%-915K

Net income

14.83%-15.52M

-1,480.32%-73.45M

18.30%-17.29M

-271.63%-14.11M

-251.85%-23.82M

-807.96%-18.22M

110.41%5.32M

-39.50%-21.16M

279.89%8.22M

198.15%15.69M

Net income continuous Operations

14.83%-15.52M

-1,480.32%-73.45M

18.30%-17.29M

-271.63%-14.11M

-251.85%-23.82M

-807.96%-18.22M

110.41%5.32M

-39.50%-21.16M

279.89%8.22M

198.15%15.69M

Minority interest income

27.91%-31K

-376.19%-100K

-88.46%3K

-80.95%-38K

-450.00%-22K

-95.45%-43K

91.50%-21K

144.83%26K

-61.54%-21K

93.10%-4K

Net income attributable to the parent company

14.80%-15.49M

-1,473.03%-73.35M

18.39%-17.29M

-270.74%-14.07M

-251.67%-23.8M

-800.31%-18.18M

110.50%5.34M

-40.20%-21.19M

280.86%8.24M

198.53%15.69M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

14.80%-15.49M

-1,473.03%-73.35M

18.39%-17.29M

-270.74%-14.07M

-251.67%-23.8M

-800.31%-18.18M

110.50%5.34M

-40.20%-21.19M

280.86%8.24M

198.53%15.69M

Basic earnings per share

16.67%-0.4

-1,464.29%-1.91

21.05%-0.45

-268.18%-0.37

-247.62%-0.62

-785.71%-0.48

107.14%0.14

-50.00%-0.57

269.23%0.22

165.63%0.42

Diluted earnings per share

16.67%-0.4

-1,464.29%-1.91

21.05%-0.45

-268.18%-0.37

-251.22%-0.62

-805.88%-0.48

107.14%0.14

-50.00%-0.57

269.23%0.22

164.06%0.41

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-98.21%802K	0	0	-98.04%334K	-96.88%468K	16,580.22%44.7M	645,800.00%6.46M	32,347.37%6.17M	48,651.43%17.06M
Operating revenue	--0	-98.21%802K	--0	--0	-98.04%334K	-96.88%468K	16,580.22%44.7M	645,800.00%6.46M	32,347.37%6.17M	48,651.43%17.06M
Cost of revenue
Gross profit
Operating expense	-21.52%16.32M	71.05%81.26M	-38.18%19.45M	4,393.95%14.9M	769.82%26.11M	56.17%20.8M	14.50%47.5M	103.56%31.46M	-107.55%-347K	-81.24%3M
Selling and administrative expenses	-50.62%5.99M	523.12%39.84M	-29.69%13.62M	108.89%961K	--13.13M	231.37%12.14M	-74.54%6.39M	97.88%19.37M	-1,013.43%-10.82M	----
-General and administrative expense	-50.62%5.99M	523.12%39.84M	-29.69%13.62M	108.89%961K	--13.13M	231.37%12.14M	-74.54%6.39M	97.88%19.37M	-1,013.43%-10.82M	----
Research and development costs	21.65%10.53M	0.74%41.41M	-51.77%5.83M	33.16%13.94M	45.99%12.98M	-10.32%8.66M	151.13%41.11M	113.35%12.1M	206.80%10.47M	144.74%8.89M
Other operating expenses	---205K	----	----	----	----	----	----	----	----	---5.89M
Operating profit	19.71%-16.32M	-2,772.30%-80.45M	22.22%-19.45M	-328.81%-14.9M	-283.33%-25.78M	-1,294.30%-20.33M	93.20%-2.8M	-61.77%-25M	242.28%6.51M	188.05%14.06M
Net non-operating interest income expense	-51.95%763K	-7.62%2.85M	-56.78%564K	-81.74%189K	-23.26%508K	17,544.44%1.59M	215.68%3.08M	7,350.00%1.31M	1.04M	662K
Non-operating interest income	-51.20%775K	-7.28%2.88M	-56.87%571K	-81.06%196K	-21.97%522K	1,813.25%1.59M	155,050.00%3.1M	--1.32M	--1.04M	--669K
Non-operating interest expense	--12K	47.37%28K	--7K	--7K	100.00%14K	--0	-99.29%19K	----	----	--7K
Other net income (expense)		90.83%1.08M	50.00%774K	-2K	507.84%310K		107.82%567K	54.03%516K		1,800.00%51K
Other non- operating income (expenses)	----	90.83%1.08M	50.00%774K	---2K	507.84%310K	----	70.78%567K	54.03%516K	----	1,800.00%51K
Income before tax	16.98%-15.56M	-9,102.59%-76.52M	21.88%-18.11M	-294.95%-14.71M	-268.95%-24.96M	-1,195.21%-18.74M	101.66%850K	-53.13%-23.18M	264.89%7.55M	192.49%14.77M
Income tax	92.83%-37K	31.22%-3.08M	59.39%-820K	10.53%-603K	-24.15%-1.14M	40.21%-516K	-15,867.86%-4.47M	-6,409.38%-2.02M	-9,528.57%-674K	-7,725.00%-915K
Net income	14.83%-15.52M	-1,480.32%-73.45M	18.30%-17.29M	-271.63%-14.11M	-251.85%-23.82M	-807.96%-18.22M	110.41%5.32M	-39.50%-21.16M	279.89%8.22M	198.15%15.69M
Net income continuous Operations	14.83%-15.52M	-1,480.32%-73.45M	18.30%-17.29M	-271.63%-14.11M	-251.85%-23.82M	-807.96%-18.22M	110.41%5.32M	-39.50%-21.16M	279.89%8.22M	198.15%15.69M
Minority interest income	27.91%-31K	-376.19%-100K	-88.46%3K	-80.95%-38K	-450.00%-22K	-95.45%-43K	91.50%-21K	144.83%26K	-61.54%-21K	93.10%-4K
Net income attributable to the parent company	14.80%-15.49M	-1,473.03%-73.35M	18.39%-17.29M	-270.74%-14.07M	-251.67%-23.8M	-800.31%-18.18M	110.50%5.34M	-40.20%-21.19M	280.86%8.24M	198.53%15.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	14.80%-15.49M	-1,473.03%-73.35M	18.39%-17.29M	-270.74%-14.07M	-251.67%-23.8M	-800.31%-18.18M	110.50%5.34M	-40.20%-21.19M	280.86%8.24M	198.53%15.69M
Basic earnings per share	16.67%-0.4	-1,464.29%-1.91	21.05%-0.45	-268.18%-0.37	-247.62%-0.62	-785.71%-0.48	107.14%0.14	-50.00%-0.57	269.23%0.22	165.63%0.42
Diluted earnings per share	16.67%-0.4	-1,464.29%-1.91	21.05%-0.45	-268.18%-0.37	-251.22%-0.62	-805.88%-0.48	107.14%0.14	-50.00%-0.57	269.23%0.22	164.06%0.41
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall